H.C. Wainwright analyst Ed Arce reiterated a Neutral rating on Assembly Biosciences (NASDAQ: ASMB).The analyst commented: "Yesterday, Assembly announced an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE